The Level of Cardiovascular Risk Factors in Bipolar Disorder Equals That of Schizophrenia: A Comparative Study

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works

The metabolic syndrome

Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,283 · see citing works

The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance

Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982 · see citing works

The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description

Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336 · see citing works

The Metabolic Syndrome: Time for a Critical Appraisal

Kahn, R., Buse, J. B., Ferrannini, E., & D, M. P. S. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,389 · see citing works

The Inventory of Depressive Symptomatology (IDS): Psychometric properties

Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · see citing works

Association between obesity and psychiatric disorders in the US adult population

Simon, G. E., Von Korff, M., Saunders, K., Miglioretti, D. L., Crane, P. K., van Belle, G., & Kessler, R. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.824 · Cited by 1,338 · see citing works

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

Mcevoy, J., Meyer, J., Goff, D., Nasrallah, H., Davis, S., Sullivan, L., Meltzer, H., Hsiao, J. K., Stroup, T., & Lieberman, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,220 · see citing works

Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women

Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135 · see citing works

The Need to Feed

Saper, C. B., Chou, T. C., & Elmquist, J. K. (2002) · Neuron · doi:10.1016/s0896-6273(02)00969-8 · Cited by 1,120 · see citing works

Excess Mortality in Bipolar and Unipolar Disorder in Sweden

Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · see citing works

Mortality of patients with mood disorders: follow-up over 34–38 years

Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00377-9 · Cited by 881 · see citing works

Excess mortality of schizophrenia: A meta-analysis

Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869 · see citing works

Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia

Ryan, M. C. M., Collins, P. B., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828 · see citing works

Mortality and causes of death in schizophrenia in Stockholm County, Sweden

Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · see citing works

Diet, smoking and cardiovascular risk in people with schizophrenia

McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.6.534 · Cited by 494 · see citing works

The Increasing Medical Burden in Bipolar Disorder

Kupfer, D. J. (2005) · JAMA · doi:10.1001/jama.293.20.2528 · Cited by 489 · see citing works

The Oslo Health Study: The impact of self-selection in a large, population-based survey

Søgaard, A. J., Selmer, R. M., Bjertness, E., & Thelle, D. S. (2004) · International Journal for Equity in Health · doi:10.1186/1475-9276-3-3 · Cited by 466 · see citing works

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

Fagiolini, A. M., Frank, E., Scott, J., Turkin, S. R., & Kupfer, D. J. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00234.x · Cited by 451 · see citing works

Correlates of overweight and obesity in 644 patients with bipolar disorder.

McElroy, S., Frye, M., Suppes, T., Dhavale, D. M., Keck, P., Leverich, G., Altshuler, L., Denicoff, K., Nolen, W., Kupka, R., et al. (2002) · Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0306 · Cited by 344 · see citing works

ETHNIC DIFFERENCES IN CARDIOVASCULAR DISEASE

Chaturvedi, N. (2003) · Heart · doi:10.1136/heart.89.6.681 · Cited by 321 · see citing works

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

Binder, M. D., van Winkel, R., Eyck, D. V., Hanssens, L., Wampers, M., Scheen, A. J., & Peuskens, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.855 · Cited by 314 · see citing works

Elevated Frequency of Diabetes Mellitus in Hospitalized Manic-Depressive Patients

Cassidy, F., Ahearn, E. P., & Carroll, B. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1417 · Cited by 300 · see citing works

Characterizing Coronary Heart Disease Risk in Chronic Schizophrenia: High Prevalence of the Metabolic Syndrome

Cohn, T. A., Prud’homme, D., Streiner, D. L., Kameh, H., & Remington, G. J. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901106 · Cited by 290 · see citing works

Bipolar Disorder, Obesity, and Pharmacotherapy-Associated Weight Gain

Keck, P. E., & McElroy, S. L. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1205 · Cited by 235 · see citing works

Prevalence of Obesity and Weight Change During Treatment in Patients With Bipolar I Disorder

Fagiolini, A. M., Frank, E., Houck, P. R., Mallinger, A. G., Swartz, H. A., Buysse, D. J., Ombao, H., & Kupfer, D. J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0611 · Cited by 202 · see citing works

Prevalence of Overweight and Obesity in Bipolar Patients

Elmslie, J. L., Silverstone, J. T., Mann, J. I., Williams, S. M., & Romans, S. E. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0306 · Cited by 193 · see citing works

Atypical antipsychotics related metabolic syndrome in bipolar patients

Yumru, M., SAVAS, H. A., Kurt, E., Kaya, M., Selek, S., Savaş, E., Oral, E., & Atagün, M. İ. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.009 · Cited by 142 · see citing works

Can cardiovascular risk factors and lifestyle explain the educational inequalities in mortality from ischaemic heart disease and from other heart diseases? 26 year follow up of 50 000 Norwegian men and women

Strand, B. H., & Tverdal, A. (2004) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2003.014563 · Cited by 123 · see citing works

Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia

Johannessen, L., Strudsholm, U., Foldager, L., & Munk‐Jørgensen, P. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.03.027 · Cited by 109 · see citing works

BLOOD SUGAR STUDIES IN DEMENTIA PRAECOX AND MANIC-DEPRESSIVE INSANITY

Raphael, T. (1921) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1921.02180300052005 · Cited by 74 · see citing works

Sociodemographic Characteristics and Cardiovascular Risk Factors in Patients With Severe Mental Disorders Compared With the General Population

Birkenaes, A. B., Søgaard, A. J., Engh, J. A., Jónsdóttir, H., Ringen, P. A., Vaskinn, A., Friis, S., Sundet, K. S., Opjordsmoen, S., & Andreassen, O. A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0314 · Cited by 60 · see citing works

The Metabolic Syndrome: Perhaps an Etiologic Mystery but Far From a Myth -- Where Does the International Diabetes Federation Stand?

Zimmet, P., & Alberti, K. G. M. M. (2005) · Cited by 28 · see citing works

Excess early mortality in schizophrenia.

Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · see citing works

Can bipolar disorder be viewed as a multi-system inflammatory disease?

Leboyer, M., Soreca, I., Scott, J., Frye, M., Henry, C., Tamouza, R., & Kupfer, D. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.049 · Cited by 417 · see citing works

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions

Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 347 · see citing works

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls

Vancampfort, D., Wampers, M., Mitchell, A. J., Correll, C. U., Herdt, A. D., Probst, M., & Binder, M. D. (2013) · World Psychiatry · doi:10.1002/wps.20069 · Cited by 320 · see citing works

Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder

Laursen, T. M., Munk-Olsen, T., Agerbo, E., Gasse, C., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.61 · Cited by 271 · see citing works

Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States

Goldstein, B. I., Fagiolini, A., Houck, P., & Kupfer, D. J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00735.x · Cited by 259 · see citing works

The epidemiology of excess mortality in people with mental illness

Lawrence, D., Kisely, S., & Pais, J. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005501202 · Cited by 258 · see citing works

Severe Mental Illness and Cardiovascular Disease

Goldfarb, M., Binder, M. D., Detraux, J., Palo, K. E. D., Munir, H., Music, S., Piña, I. L., & Ringen, P. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.017 · Cited by 250 · see citing works

Cardiovascular Morbidity and Mortality in Bipolar Disorder

Weiner, M., Warren, L. L., & Fiedorowicz, J. G. (2011) · Annals of Clinical Psychiatry · doi:10.1177/104012371102300107 · Cited by 221 · see citing works

Smoking, nicotine and neuropsychiatric disorders

Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 215 · see citing works

Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort

Athanasiu, L., Mattingsdal, M., Kähler, A. K., Brown, A. A., Gústafsson, Ó., Agartz, I., Giegling, I., Muglia, P., Cichon, S., Rietschel, M., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.002 · Cited by 210 · see citing works

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons

Fraguas, D., Correll, C. U., Merchán‐Naranjo, J., Rapado‐Castro, M., Parellada, M., Moreno, C., & Arango, C. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.002 · Cited by 209 · see citing works

Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden

Westman, J., Hällgren, J., Wahlbeck, K., Erlinge, D., Alfredsson, L., & Ösby, U. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002373 · Cited by 204 · see citing works

Coronavirus Immunoreactivity in Individuals With a Recent Onset of Psychotic Symptoms

Severance, E. G., Dickerson, F., Viscidi, R. P., Bossis, I., Stallings, C. R., Origoni, A. E., Sullens, A., & Yolken, R. H. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp052 · Cited by 190 · see citing works

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

Ng, F., Mammen, O. K., Wilting, I., Sachs, G. S., Ferrier, I. N., Cassidy, F., Beaulieu, S., Yatham, L. N., & Berk, M. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00737.x · Cited by 192 · see citing works

Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors

Kilbourne, A. M., Morden, N. E., Austin, K., Ilgen, M. A., McCarthy, J. F., Dalack, G. W., & Blow, F. C. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.07.008 · Cited by 181 · see citing works

The burden of obesity among adults with bipolar disorder in the United States

Goldstein, B. I., Liu, S.-M., Zivkovic, N., Schaffer, A., Chien, L.-C., & Blanco, C. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00932.x · Cited by 173 · see citing works

Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder

Fiedorowicz, J. G., Solomon, D. A., Endicott, J., Leon, A. C., Li, C., Rice, J. P., & Coryell, W. H. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181acee26 · Cited by 167 · see citing works

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second‐generation antipsychotics

Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00625.x · Cited by 158 · see citing works

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

Hope, S., Melle, I. S., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., Agartz, I., Ueland, T., & Andreassen, O. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00757.x · Cited by 152 · see citing works

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients

Drexhage, R. C., van der Heul-Nieuwenhuijsen, L., Padmos, R. C., van Beveren, N. J. M., Cohen, D., Versnel, M. A., Nolen, W. A., & Drexhage, H. A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000799 · Cited by 152 · see citing works

Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems

SayuriYamagata, A., Brietzke, E. M., Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.059 · Cited by 153 · see citing works

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

Hope, S., Ueland, T., Steen, N. E., Dieset, I., Lorentzen, S., Berg, A. O., Agartz, I., Aukrust, P., & Andreassen, O. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.023 · Cited by 131 · see citing works

A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults

Jackson, J. G., Diaz, F. J., Lopez, L., & de Leon, J. (2015) · Bipolar Disorders · doi:10.1111/bdi.12319 · Cited by 120 · see citing works

Boosting the Power of Schizophrenia Genetics by Leveraging New Statistical Tools

Andreassen, O. A., Thompson, W. K., & Dale, A. M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt168 · Cited by 112 · see citing works

Dyslipidemia Independent of Body Mass in Antipsychotic-Treated Patients Under Real-Life Conditions

Birkenaes, A. B., Birkeland, K. I., Engh, J. A., Færden, A., Jónsdóttir, H., Ringen, P. A., Friis, S., Opjordsmoen, S., & Andreassen, O. A. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166c4f7 · Cited by 114 · see citing works

Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders

Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 112 · see citing works

Do Stroke Patients have an Increased Risk of Developing Suicidal Ideation or Dying by Suicide? An Overview of the Current Literature

Pompili, M., Venturini, P., Campi, S., Seretti, M. E., Montebovi, F., Lamis, D. A., Serafini, G., Amore, M., & Girardi, P. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00364.x · Cited by 111 · see citing works

Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review

Levin, J. B., Krivenko, A., Howland, M., Schlachet, R., & Sajatovic, M. (2016) · CNS Drugs · doi:10.1007/s40263-016-0368-x · Cited by 114 · see citing works

Immunity, Inflammation, and Bipolar Disorder: Diagnostic and Therapeutic Implications

Hamdani, N., Doukhan, R., Kurtlucan, O., Tamouza, R., & Leboyer, M. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0387-y · Cited by 103 · see citing works

The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample

Fiedorowicz, J. G., He, J., & Merikangas, K. R. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.07.010 · Cited by 98 · see citing works

Identifying Common Genetic Variants in Blood Pressure Due to Polygenic Pleiotropy With Associated Phenotypes

Andreassen, O. A., McEvoy, L. K., Thompson, W. K., Wang, Y., Reppe, S., Schork, A. J., Zuber, V., Barrett-Connor, E. L., Gautvik, K. M., Aukrust, P., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02077 · Cited by 88 · see citing works

Suicide in Stroke Survivors: Epidemiology and Prevention

Pompili, M., Venturini, P., Lamis, D. A., Giordano, G., Serafini, G., Murri, M. B., Amore, M., & Girardi, P. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0233-x · Cited by 87 · see citing works

The impact of mental illness on cardiac outcomes: A review for the cardiologist

Sowden, G. L., & Huffman, J. C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.002 · Cited by 86 · see citing works

Balancing Efficacy and Safety in Treatment with Antipsychotics

Correll, C. U. (2007) · CNS Spectrums · doi:10.1017/s1092852900026298 · Cited by 85 · see citing works

Bipolar Disorder and Metabolic Syndrome: A Systematic Review

Czepielewski, L. S., Filho, L. D., Brietzke, E. M., & Grassi‐Oliveira, R. (2013) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.07.004 · Cited by 81 · see citing works

Health Care for Patients with Serious Mental Illness: Family Medicine's Role

Morden, N. E., Mistler, L. A., Weeks, W. B., & Bartels, S. J. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.02.080059 · Cited by 77 · see citing works

Cardiovascular risk in patients with bipolar disorder

García‐Portilla, M. P., Sáiz, P. A., Bobes-Bascarán, T., Martíneza, S., Benabarre, A., Sierra, P., Torres, P., Montes, J. M. G., Bousoño, M., & Bobes, J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.008 · Cited by 76 · see citing works

Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls

Quintana, D. S., Westlye, L. T., Kaufmann, T., Rustan, Ø. G., Brandt, C. L., Haatveit, B., Steen, N. E., & Andreassen, O. A. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12498 · Cited by 73 · see citing works

Subcortical brain volumes relate to neurocognition in schizophrenia and bipolar disorder and healthy controls

Hartberg, C. B., Sundet, K. S., Rimol, L. M., Haukvik, U. K., Lange, E. H., Nesvåg, R., Melle, I. S., Andreassen, O. A., & Agartz, I. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.014 · Cited by 78 · see citing works

TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders

Wirgenes, K. V., Sønderby, I. E., Haukvik, U. K., Mattingsdal, M., Tesli, M., Athanasiu, L., Sundet, K. S., Røssberg, J. I., Dale, A. M., Brown, A. A., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.39 · Cited by 71 · see citing works

Appeal of electronic cigarettes in smokers with serious mental illness

Pratt, S. I., Sargent, J. D., Daniels, L., Santos, M. M., & Brunette, M. F. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.03.009 · Cited by 71 · see citing works

Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis

Onyeka, I. N., Høegh, M. C., Eien, E. M. N., Nwaru, B. I., & Melle, I. S. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1619007 · Cited by 69 · see citing works

Cardiovascular aspects of antipsychotics

Raedler, T. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833f46c9 · Cited by 89 · see citing works

Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients

Vik‐Mo, A. O., Birkenaes, A. B., Fernø, J., Jónsdóttir, H., Andreassen, O. A., & Steen, V. M. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008468 · Cited by 68 · see citing works

Bipolar Disorder and the Vascular System: Mechanisms and New Prevention Opportunities

Goldstein, B. I. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.10.006 · Cited by 64 · see citing works

Metabolic syndrome in Italian patients with bipolar disorder

Salvi, V., Albert, U., Chiarle, A., Soreca, I., Bogetto, F., & Maina, G. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.04.009 · Cited by 63 · see citing works

Managing the side effects associated with commonly used treatments for bipolar depression.

Kemp, D. E. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70007-2 · Cited by 66 · see citing works

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder

Dodd, S., Brnabic, A. J. M., Berk, L., Fitzgerald, P. B., de Castella, A. R., Filia, S., Filia, K., Kelin, K., Smith, M., Montgomery, W. S., et al. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.12.001 · Cited by 55 · see citing works

Metabolic effects of second‐generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses

Moreno, C., Merchán‐Naranjo, J., Álvarez, M., Baeza, I., Alda, J. A., Martínez‐Cantarero, C., Parellada, M., Sánchez, B., de la Serna, E., Giráldez, M., et al. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00797.x · Cited by 54 · see citing works

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Bakken, T. E., Roddey, J. C., Djurovic, S., Akshoomoff, N. A., Amaral, D. G., Bloss, C. S., Casey, B. J., Chang, L., Ernst, T. M., Gruen, J. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105829109 · Cited by 52 · see citing works

Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder

Bobo, W. V., & Shelton, R. C. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.143 · Cited by 50 · see citing works

Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function

LeBlanc, M., Kulle, B., Sundet, K. S., Agartz, I., Melle, I. S., Djurovic, S., Frigessi, A., & Andreassen, O. A. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.001 · Cited by 48 · see citing works

Prolactin Levels and Sexual Adverse Effects in Patients With Schizophrenia During Antipsychotic Treatment

Rettenbacher, M. A., Hofer, A., Ebenbichler, C. F., Baumgartner, S., Edlinger, M., Engl, J., Kaser, S., Kemmler, G., Malík, P., Tschoner, A., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181faf0e3 · Cited by 47 · see citing works

Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia

Solberg, D. K., Bentsen, H., Refsum, H., & Andreassen, O. A. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12388 · Cited by 47 · see citing works

Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade

Rødevand, L. N., Steen, N. E., Elvsåshagen, T., Quintana, D. S., Reponen, E. J., Mørch, R. H., Lunding, S. H., Vedal, T. S. J., Dieset, I., Melle, I. S., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13008 · Cited by 45 · see citing works

The incidence of cardiovascular morbidity among patients with bipolar disorder: A population-based longitudinal study in Ontario, Canada

Callaghan, R. C., & Khizar, A. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.029 · Cited by 46 · see citing works

Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population

Choong, E., Bondolfi, G., Etter, M., Jermann, F., Aubry, J., Bartolomei, J., Gholam‐Rezaee, M., & Eap, C. B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.014 · Cited by 46 · see citing works

Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments

Steardo, L., Fabrazzo, M., Sampogna, G., Monteleone, A. M., D’Agostino, G., Monteleone, P., & Maj, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.360 · Cited by 50 · see citing works

Ziprasidone and the Corrected QT Interval

Camm, A. J., Karayal, O. N., Meltzer, H. Y., Kolluri, S., O’Gorman, C., Miceli, J. J., Tensfeldt, T. G., & Kane, J. M. (2012) · CNS Drugs · doi:10.2165/11599010-000000000-00000 · Cited by 46 · see citing works

Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein

Dieset, I., Hope, S., Ueland, T., Bjella, T. D., Agartz, I., Melle, I. S., Aukrust, P., Røssberg, J. I., & Andreassen, O. A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.040 · Cited by 43 · see citing works

Increased risk of hyperlipidemia in patients with bipolar disorder: a population-based study

Hsu, J., Chien, I., & Lin, C. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.04.003 · Cited by 42 · see citing works

Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders

Mothi, S. S., Tandon, N., Padmanabhan, J. L., Mathew, I. T., Clementz, B. A., Tamminga, C. A., Pearlson, G. D., Sweeney, J. A., & Keshavan, M. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.03.034 · Cited by 41 · see citing works

Why are somatic diseases in bipolar disorder insufficiently treated?

Nielsen, R. E., Kugathasan, P., Straszek, S. P. V., Jensen, S. E., & Licht, R. W. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0147-y · Cited by 42 · see citing works

Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder

Kasteng, F., Eriksson, J. W., Sennfält, K., & Lindgren, P. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01716.x · Cited by 40 · see citing works

Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders

Quintana, D. S., Dieset, I., Elvsåshagen, T., Westlye, L. T., & Andreassen, O. A. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.12.004 · Cited by 39 · see citing works

Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics

Vuksan‐Ćusa, B., Jakovljević, M., Šagud, M., Peleš, A. M., Marčinko, D., Topić, R., Mihaljević, S., & Sertić, J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.11.021 · Cited by 39 · see citing works

Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial

Engh, J. A., Andersen, E., Holmen, T. L., Martinsen, E. W., Mordal, J., Morken, G., & Egeland, J. (2015) · Trials · doi:10.1186/s13063-015-1094-2 · Cited by 38 · see citing works

Circadian rhythms and sleep in bipolar disorder

Soreca, I. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000108 · Cited by 38 · see citing works

Disturbance of Oxidative Stress Parameters in Treatment-Resistant Bipolar Disorder and Their Association With Electroconvulsive Therapy Response

Lv, Q., Hu, Q., Zhang, W., Huang, X., Zhu, M., Geng, R., Cheng, X., Bao, C., Wang, Y., Zhang, C., et al. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa003 · Cited by 37 · see citing works

Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies

Earley, W. R., Durgam, S., Lu, K., Debelle, M., Laszlovszky, I., Vieta, E., & Yatham, L. N. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.032 · Cited by 36 · see citing works

Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study

Chen, Y., Bobo, W. V., Watts, K., Jayathilake, K., Tang, T., & Meltzer, H. Y. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111430748 · Cited by 36 · see citing works

Bipolar Disorder, Schizophrenia, and Metabolic Syndrome

Bartoli, F., Carrà, G., Crocamo, C., Carretta, D., & Clerici, M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13040447 · Cited by 35 · see citing works

Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder

Gomes, F. A., de Almeida, K. M., Magalhães, P. V. D. S., Caetano, S. C., Kauer‐Sant’Anna, M., Lafer, B., & Kapczinski, F. P. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2011-0768 · Cited by 35 · see citing works

Consenso Español de Salud Física del Paciente con Trastorno Bipolar

Bobes, J., Ruiz, J. S., Montes, J. M. G., Mostaza, J. M., Rico‐Villademoros, F., & Vieta, E. (2008) · Revista de Psiquiatría y Salud Mental · doi:10.1016/s1888-9891(08)72513-8 · Cited by 35 · see citing works

Healthy living? By whose standards? Engaging mental health service recipients to understand their perspectives of, and barriers to, healthy living.

Graham, C. R., Griffiths, B., Tillotson, S. M., & Rollings, C. (2013) · Psychiatric Rehabilitation Journal · doi:10.1037/prj0000009 · Cited by 34 · see citing works

Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder

Fjukstad, K. K., Engum, A., Lydersen, S., Dieset, I., Steen, N. E., Andreassen, O. A., & Spigset, O. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000582 · Cited by 34 · see citing works

Acute Myocardial Infarction in Severe Mental Illness: Prevalence, Clinical Outcomes, and Process of Care in U.S. Hospitalizations

Mohamed, M., Rashid, M. O., Farooq, S., Siddiqui, N., Parwani, P. J., Shiers, D., Thamman, R., Gulati, M., Shoaib, A., Chew-Graham, C. A., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.04.021 · Cited by 33 · see citing works

Metabolic syndrome in Italian patients with bipolar disorder: A 2-year follow-up study

Salvi, V., D’Ambrosio, V., Bogetto, F., & Maina, G. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.025 · Cited by 34 · see citing works

Seeing more clearly through psychosis: Depth inversion illusions are normal in bipolar disorder but reduced in schizophrenia

Keane, B. P., Silverstein, S. M., Wang, Y., Roché, M. W., & Papathomas, T. V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.015 · Cited by 34 · see citing works

The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions

Fornaro, M., Solmi, M., Veronese, N., Berardis, D. D., Buonaguro, E. F., Tomasetti, C., Perna, G., Preti, A., & Carta, M. G. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1299695 · Cited by 34 · see citing works

Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population

Lee, N. Y., Kim, S. H., Cho, B., Lee, Y. J., Chang, J. S., Kang, U. G., Kim, Y. S., & Ahn, Y. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.029 · Cited by 33 · see citing works

Cardiovascular risk factors among people with severe mental illness in Italy: A cross-sectional comparative study

Clerici, M., Bartoli, F., Carretta, D., Crocamo, C., Bebbington, P., & Carrà, G. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.08.005 · Cited by 32 · see citing works

Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden

Ösby, U., Tiainen, A., Backlund, L., Edman, G., Adler, M., Hällgren, J., Sennfält, K., van Baardewijk, M., & Sparén, P. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.011 · Cited by 32 · see citing works

Schizophrenia and the incidence of cardiovascular morbidity: A population-based longitudinal study in Ontario, Canada

Callaghan, R. C., Boire, M. D., Lazo, R. G., McKenzie, K. J., & Cohn, T. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.018 · Cited by 31 · see citing works

Sex-specific cortisol levels in bipolar disorder and schizophrenia during mental challenge — Relationship to clinical characteristics and medication

Steen, N. E., Lorentzen, S., Barrett, E. A., Lagerberg, T. V., Hope, S., Larsson, S., Berg, A. O., Agartz, I., Melle, I. S., Berg, J. P., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.008 · Cited by 31 · see citing works

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics

Oh, J.-E., Cho, Y. M., Kwak, S.-N., Kim, J. H., Lee, K., Jung, H., Jeong, S., & Kwon, O.-J. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.9.062 · Cited by 30 · see citing works

Increased Risk of Acute Myocardial Infarction After Acute Episode of Schizophrenia: 6 Year Follow-Up Study

Lin, H.-C., Chen, Y., Lee, H.-C., & Lin, H. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903487209 · Cited by 30 · see citing works

The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Sud, D., Laughton, E., McAskill, R., Bradley, E., & Maidment, I. D. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01586-9 · Cited by 30 · see citing works

Treatment of bipolar disorder: New perspectives

Alda, M., Hájek, T., Calkin, C. V., & O’Donovan, C. (2008) · Annals of Medicine · doi:10.1080/07853890802409489 · Cited by 29 · see citing works

Hormonal Markers of Metabolic Dysregulation in Patients With Severe Mental Disorders After Olanzapine Treatment Under Real-Life Conditions

Birkenaes, A. B., Birkeland, K., Friis, S., Opjordsmoen, S., & Andreassen, O. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819b95fc · Cited by 32 · see citing works

Prevalence of metabolic syndrome in bipolar patients initiating acute‐phase treatment: A 6‐month follow up

Guan, N., Liu, H., Diao, F., Zhang, J., Zhang, M., & Wu, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02150.x · Cited by 28 · see citing works

Selfish brain and neuroprogression in bipolar disorder.

Mansur, R., Cha, D., Asevedo, E., McIntyre, R., & Brietzke, E. (2013) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.004 · Cited by 27 · see citing works

Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management

Łojko, D., Owecki, M., & Suwalska, A. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16071132 · Cited by 27 · see citing works

Plasma oxysterols: Altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder

Guidara, W., Messedi, M., Maalej, M., Naifar, M., Khrouf, W., Grayaa, S., Maalej, M. A., Bonnefont‐Rousselot, D., Lamari, F., & Ayadi, F. M. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105902 · Cited by 25 · see citing works

Increased Risks of Death and Hospitalization in Influenza/Pneumonia and Sepsis for Individuals Affected by Psychotic Disorders, Bipolar Disorders, and Single Manic Episodes: A Retrospective Cross-Sectional Study

Nilsson, N., Bendix, M., Öhlund, L., Widerström, M., Werneke, U., & Maripuu, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194411 · Cited by 25 · see citing works

Osteoprotegerin levels in patients with severe mental disorders

Hope, S., Melle, I. S., Aukrust, P., Agartz, I., Lorentzen, S., Steen, N. E., Djurovic, S., Ueland, T., & Andreassen, O. A. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090088 · Cited by 24 · see citing works

Is cardiac autonomic control affected in major depressive disorder? A systematic review of heart rate variability studies

Goffi, F., Maggioni, E., Bianchi, A. M., Brambilla, P., & Delvecchio, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03430-3 · Cited by 26 · see citing works

A Qualitative Study Exploring Facilitators for Improved Health Behaviors and Health Behavior Programs: Mental Health Service Users’ Perspectives

Graham, C. R., Rollings, C., de Leeuw, S., Anderson, L., Griffiths, B., & Long, N. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/870497 · Cited by 23 · see citing works

SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders

Steen, N. E., Tesli, M., Kähler, A. K., Methlie, P., Hope, S., Barrett, E. A., Larsson, S., Mork, E., Løvås, K., Røssberg, J. I., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.013 · Cited by 21 · see citing works

The general problem of increased somatic comorbidity in bipolar patients

Bobes, J. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-s1-s32 · Cited by 1 · see citing works

S96. CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER

Rødevand, L. N., Steen, N. E., Quintana, D. S., Reponen, E. J., Mørch, R. H., Lunding, S. H., Iversen, T., Lagerberg, T. V., Melle, I. S., & Andreassen, O. A. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby018.883

Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade

Rødevand, L. N., Steen, N. E., Elvsåshagen, T., Quintana, D. S., Reponen, E. J., Mørch, R. H., Lunding, S. H., Vedal, T. S. J., Dieset, I., Melle, I. S., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13008 · Cited by 45 · see citing works

Elevated Cardiovascular Risk in Patients With Bipolar Disorder: When Does It Start and Where Does It Lead?

Correll, C. U. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1214 · Cited by 17 · see citing works

Medical Risk in Patients With Bipolar Disorder and Schizophrenia

Newcomer, J. W. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.1106e16 · Cited by 264 · see citing works